Opioid Abuse or Stock Abuse: The PetMed Short Report Controversy

While the U.S. struggles to properly address the continued opioid epidemic, short seller Aurelius Value has leveled accusations of exploiting the crisis against animal medication supplier PetMed. The Benzinga newsdesk examines whether the claims of marketing pet pain receivers to opioid addicts are legitimate or if Aurelius is involved in some exploitation of their own. Subscribe to BenzingaTV for more market updates, trading ideas, and the latest financial news. Find full articles and analysis at Benzinga.com. For free trial access to professional analyst coverage and market moving exclusive news, visit pro.benzinga.com ----- Follow us on Twitter: twitter.com/Benzinga Like us on Facebook: facebook.com/Benzinga Connect with us on LinkedIn: linkedin.com/company/Benzinga ------ Benzinga is a dynamic financial media outlet that empowers investors with real-time news and unique market analysis. Headquartered in the heart of Detroit, Benzinga provides timely, actionable ideas that help traders and investors navigate even the most uncertain and volatile markets.